Viruses that infect and kill bacteria and have been identified as a possible alternative or complement to antibiotic treatment.
Phage therapy is used in a small number of countries, and whilst single patient success has been reported, development of these treatments is challenging; multiple clinical trials are ongoing.
Phage therapy in the resistance era: Where do we stand and where are we going? (Clinical Therapeutics, 2020)
Resistance evolution against phage combinations depends on the timing and order of Exposure (mBio, 2020)
Bacteriophage treatment: critical evaluation of its application on world health organization priority pathogens (Viruses, 2021)
Phage therapy in the postantibiotic era (Clinical Microbiology Reviews, 2019)
Current challenges and future opportunities of phage therapy (FRMS Microbiology Reviews, 2020)